Maria E Cantor
CIK 1542768 · SVP, Investor Rel. & Comm. · last filed 2018-01-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ARIA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QURE | SVP, Investor Rel. & Comm. | 92,439 | $24.83 | $2.30M | -$118.0K | 5 | 2018-01-30 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | SVP, Corporate Affairs | 149,001 | $23.09 | $3.44M | -$1.90M | 34 | 2016-05-02 |
Recent Filings · Page 3 of 4
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-03-21 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +8,105 | -$45.8K | EDGAR |
| 2014-02-04 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-20 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +6,375 | -$32.8K | EDGAR |
| 2013-07-18 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Sell (S) | −8,000 | -$158.3K | EDGAR |
| 2013-07-17 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +16,000 | $0 | EDGAR |
| 2013-04-03 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +4,250 | -$76.7K | EDGAR |
| 2013-03-26 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +12,123 | -$113.9K | EDGAR |
| 2013-03-22 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +3,667 | -$71.3K | EDGAR |
| 2013-03-20 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-03-13 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Sell (S) | −2,105 | -$46.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.